Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
11.508 / 17.034
#92057

Re: Farmas USA

De toda la vida :)

por cierto en el repaso me he dado cuenta de lo que mencionábamos lo de los institucionales en una compañía, y la verdad que algunas cuantas con más del 90% se pegaron unas hostias terribles(VVUS,ACHN esta se recupero, hay muchos ejemplos)
No te lo tomes a mal, son reflexiones, no quiero decir que vaya a pasar con Nvax.

#92059

Re: Farmas USA

Un consejo...hoy no la veas ....déjala para el fin de semana que la cosa será muy diferente....😉

#92061

Re: Farmas USA

Ahhhh mira porque la sujetaban post-news

 

Amarin Announces Proposed Public Offering of American Depositary Shares

 

 

BEDMINSTER, N.J., and DUBLIN, Ireland, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it has commenced an underwritten public offering of its American Depositary pursuant to a shelf registration.  All of the shares in the proposed offering are to be sold by Amarin.  The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

Jefferies LLC and Citigroup Global Markets Inc. are acting as joint book-running managers in the offering. Cantor Fitzgerald & Co. is acting as lead manager and H.C. Wainwright & Co. and SunTrust Robinson Humphrey are acting as co-managers in this offering. Amarin intends to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the shares sold in the offering, on the same terms and conditions.

The securities described above are being offered by Amarin pursuant to a shelf registration statement on Form S-3 (No. 333-197936) previously filed with the Securities and Exchange Commission (the "SEC") on August 7, 2014 and declared effective by the SEC on August 22, 2014. A preliminary prospectus supplement related to the offering will be filed with the SEC and will be available on the SEC's website at  http://www.sec.gov. Copies of the preliminary prospectus supplement relating to these securities may be obtained from Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at  (877) 821-7388 or by email at  [email protected] or from Citigroup Global Markets Inc., c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at  (800) 831-9146.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there by any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.